World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VKTXViking Therapeutics | $5.85bn | n/a | n/a |
TEMTempus AI | $5.77bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
SMMTSummit Therapeutics | $5.48bn | n/a | n/a |
KRYSKrystal Biotech | $5.24bn | n/a | n/a |
BIOCONBiocon | IN₹421.53bn | 44.59 | 0.14% |
NUVLNuvalent | $4.90bn | n/a | n/a |
950160Kolon TissueGene | KR₩7tn | n/a | n/a |
6990Sichuan Kelun-Biotech Biopharmaceutical Co | HK$36.95bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $4.59bn | n/a | n/a |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
ALPNAlpine Immune Sciences | $4.46bn | n/a | n/a |
IBRXImmunitybio | $4.37bn | n/a | n/a |
9926Akeso | HK$32.69bn | 14.52 | n/a |
MRTXMirati Therapeutics | $4.12bn | n/a | n/a |
ALKSAlkermes | $4.08bn | 6.84 | n/a |
ALKSVAlkermes | $4.05bn | 18.02 | n/a |
MRUSMerus NV | $3.99bn | n/a | n/a |
TLXTelix Pharmaceuticals | AU$5.86bn | 1021.46 | n/a |
IMVTImmunovant | $3.86bn | n/a | n/a |